Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
sulfoquinovosyl dipalmitoyl glyceride | [no description available] | medium | 1 | 0 | | |
dimyristoylphosphatidylglycerol | [no description available] | medium | 15 | 0 | | |
glycolipids | [no description available] | medium | 3 | 0 | | |
dimyristoylphosphatidylcholine | [no description available] | medium | 107 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine; phosphatidylcholine 28:0; tetradecanoate ester | antigen; mouse metabolite |
rivastigmine | [no description available] | medium | 1 | 0 | carbamate ester; tertiary amino compound | cholinergic drug; EC 3.1.1.8 (cholinesterase) inhibitor; neuroprotective agent |
epirubicin | [no description available] | medium | 1 | 0 | aminoglycoside; anthracycline antibiotic; anthracycline; deoxy hexoside; monosaccharide derivative; p-quinones; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone | antimicrobial agent; antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
1,1-diphenyl-2-picrylhydrazyl | [no description available] | medium | 1 | 0 | | |
1,2-dioleoylphosphatidylserine | [no description available] | medium | 1 | 0 | phosphatidylserine(18:1/18:1) | mouse metabolite |
alpha-synuclein | [no description available] | medium | 1 | 0 | | |
labetalol | [no description available] | medium | 1 | 0 | benzamides; benzenes; phenols; primary carboxamide; salicylamides; secondary alcohol; secondary amino compound | |
miltefosine | [no description available] | medium | 1 | 0 | phosphocholines; phospholipid | anti-inflammatory agent; anticoronaviral agent; antifungal agent; antineoplastic agent; antiprotozoal drug; apoptosis inducer; immunomodulator; protein kinase inhibitor |
phosphorylcholine | [no description available] | medium | 2 | 0 | phosphocholines | allergen; epitope; hapten; human metabolite; mouse metabolite |
catechin | [no description available] | medium | 1 | 0 | catechin | antioxidant; plant metabolite |
hypochlorous acid | [no description available] | medium | 3 | 0 | chlorine oxoacid; reactive oxygen species | EC 2.5.1.18 (glutathione transferase) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; human metabolite |
epigallocatechin gallate | [no description available] | medium | 1 | 0 | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
dioleoyl phosphatidylethanolamine | [no description available] | medium | 2 | 0 | phosphatidylethanolamine | |
d-alpha tocopherol | [no description available] | medium | 4 | 0 | alpha-tocopherol | algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite |
6-carboxyfluorescein | [no description available] | medium | 1 | 0 | monocarboxylic acid | |
1-palmitoyl-2-oleoylphosphatidylethanolamine | [no description available] | medium | 4 | 0 | (18R,21S)-24-amino-21-hydroxy-21-oxido-15-oxo-16,20,22-trioxa-21lambdalambda(5)-phosphatetracosan-18-yl icosanoate; phosphatidylethanolamine | |
erythrosine | [no description available] | medium | 2 | 0 | | |
fluorescein-5-isothiocyanate | [no description available] | medium | 3 | 0 | fluorescein isothiocyanate | |
valproic acid | [no description available] | medium | 1 | 0 | branched-chain fatty acid; branched-chain saturated fatty acid | anticonvulsant; antimanic drug; EC 3.5.1.98 (histone deacetylase) inhibitor; GABA agent; neuroprotective agent; psychotropic drug; teratogenic agent |
donepezil | [no description available] | medium | 1 | 0 | aromatic ether; indanones; piperidines; racemate | EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; nootropic agent |
3-phenylenediamine | [no description available] | medium | 1 | 0 | phenylenediamine | |
acetyl coenzyme a | [no description available] | medium | 2 | 0 | acyl-CoA | acyl donor; coenzyme; effector; fundamental metabolite |
vanadates | [no description available] | medium | 2 | 0 | trivalent inorganic anion; vanadium oxoanion | EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor |
edetic acid | [no description available] | medium | 1 | 0 | | |
solanine | [no description available] | medium | 1 | 0 | | |
diosgenin | [no description available] | medium | 1 | 0 | 3beta-sterol; hexacyclic triterpenoid; sapogenin; spiroketal | antineoplastic agent; antiviral agent; apoptosis inducer; metabolite |
merocyanine dye | [no description available] | medium | 1 | 0 | | |
pyrimidinones | [no description available] | medium | 1 | 0 | | |
dimyristoylphosphatidylserine | [no description available] | medium | 2 | 0 | | |
salicylic acid | [no description available] | medium | 1 | 0 | monohydroxybenzoic acid | algal metabolite; antifungal agent; antiinfective agent; EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor; keratolytic drug; plant hormone; plant metabolite |
aspirin | [no description available] | medium | 2 | 0 | benzoic acids; phenyl acetates; salicylates | anticoagulant; antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; EC 1.1.1.188 (prostaglandin-F synthase) inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; plant activator; platelet aggregation inhibitor; prostaglandin antagonist; teratogenic agent |
paclitaxel | [no description available] | medium | 1 | 0 | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent |
1,2-distearoylphosphatidylethanolamine | [no description available] | medium | 5 | 0 | phosphatidylethanolamine zwitterion; phosphatidylethanolamine | human metabolite |
resveratrol | [no description available] | medium | 1 | 0 | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger |
stilbenes | [no description available] | medium | 1 | 0 | stilbene | |
cholestanol | [no description available] | medium | 3 | 0 | cholestanoid | |
nalidixic acid | [no description available] | medium | 1 | 0 | 1,8-naphthyridine derivative; monocarboxylic acid; quinolone antibiotic | antibacterial drug; antimicrobial agent; DNA synthesis inhibitor |
calixarenes | [no description available] | medium | 2 | 0 | | |
propranolol | [no description available] | medium | 1 | 0 | naphthalenes; propanolamine; secondary amine | anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic |
amantadine | [no description available] | medium | 1 | 0 | adamantanes; primary aliphatic amine | analgesic; antiparkinson drug; antiviral drug; dopaminergic agent; NMDA receptor antagonist; non-narcotic analgesic |
1,2-dipalmitoylphosphatidylcholine | [no description available] | medium | 20 | 0 | | |
1,2-oleoylphosphatidylcholine | [no description available] | medium | 6 | 0 | phosphatidylcholine(1+) | |
phosphatidylcholines | [no description available] | medium | 30 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine | |
ethyldimethylaminopropyl carbodiimide | [no description available] | medium | 1 | 0 | | |
usnic acid | [no description available] | medium | 1 | 0 | benzofurans | |
benzofurans | [no description available] | medium | 1 | 0 | | |
pentetic acid | [no description available] | medium | 7 | 0 | pentacarboxylic acid | copper chelator |
thimerosal | [no description available] | medium | 1 | 0 | alkylmercury compound | antifungal drug; antiseptic drug; disinfectant; drug allergen |
10,12-tricosadiynoic acid | [no description available] | medium | 1 | 0 | very long-chain fatty acid | |
memantine | [no description available] | medium | 1 | 0 | adamantanes; primary aliphatic amine | antidepressant; antiparkinson drug; dopaminergic agent; neuroprotective agent; NMDA receptor antagonist |
lipid a | [no description available] | medium | 1 | 0 | dodecanoate ester; lipid A; tetradecanoate ester | Escherichia coli metabolite |
limestone | [no description available] | medium | 1 | 0 | calcium salt; carbonate salt; inorganic calcium salt; one-carbon compound | antacid; fertilizer; food colouring; food firming agent |
ozone | [no description available] | medium | 1 | 0 | elemental molecule; gas molecular entity; reactive oxygen species; triatomic oxygen | antiseptic drug; disinfectant; electrophilic reagent; greenhouse gas; mutagen; oxidising agent; tracer |
3-hydroxy-5-oxo-5,6-secocholestan-6-al | [no description available] | medium | 1 | 0 | | |
phenytoin | [no description available] | medium | 1 | 0 | imidazolidine-2,4-dione | anticonvulsant; drug allergen; sodium channel blocker; teratogenic agent |
diclofenac | [no description available] | medium | 1 | 0 | amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound | antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
1,2-dilauroylphosphatidylcholine | [no description available] | medium | 1 | 0 | 1,2-diacyl-sn-glycero-3-phosphocholine(1+) | |
manganese | [no description available] | medium | 1 | 0 | elemental manganese; manganese group element atom | Escherichia coli metabolite; micronutrient |
laurdan | [no description available] | medium | 2 | 0 | | |
guanidine | [no description available] | medium | 1 | 0 | carboxamidine; guanidines; one-carbon compound | |
2-naphthylamine | [no description available] | medium | 2 | 0 | naphthylamine | carcinogenic agent |
arginine | [no description available] | medium | 2 | 0 | arginine; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid | biomarker; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical |
naproxen | [no description available] | medium | 1 | 0 | methoxynaphthalene; monocarboxylic acid | antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; environmental contaminant; gout suppressant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic |
cholesteryl succinate | [no description available] | medium | 1 | 0 | cholestane ester; dicarboxylic acid monoester; hemisuccinate | detergent |
alpha-glycerophosphoric acid | [no description available] | medium | 1 | 0 | glycerol monophosphate | algal metabolite; human metabolite |
iridium radioisotopes | [no description available] | medium | 1 | 0 | | |
3-tyr-octreotide | [no description available] | medium | 1 | 0 | | |
mobiflex | [no description available] | medium | 1 | 0 | heteroaryl hydroxy compound; monocarboxylic acid amide; pyridines; thienothiazine | antipyretic; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
piroxicam | [no description available] | medium | 1 | 0 | benzothiazine; monocarboxylic acid amide; pyridines | analgesic; antirheumatic drug; cyclooxygenase 1 inhibitor; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug |
mobic | [no description available] | medium | 1 | 0 | 1,3-thiazoles; benzothiazine; monocarboxylic acid amide | analgesic; antirheumatic drug; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
thiazoles | [no description available] | medium | 1 | 0 | 1,3-thiazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene | |
quinazolines | [no description available] | medium | 1 | 0 | azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; quinazolines | |
gold | [no description available] | medium | 3 | 0 | copper group element atom; elemental gold | |
vitamin k 3 | [no description available] | medium | 1 | 0 | 1,4-naphthoquinones; vitamin K | angiogenesis inhibitor; antineoplastic agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor; human urinary metabolite; nutraceutical |
perfluorooctane sulfonic acid | [no description available] | medium | 1 | 0 | perfluoroalkanesulfonic acid | antilipemic drug; persistent organic pollutant |
rhodamine b | [no description available] | medium | 1 | 0 | organic chloride salt; xanthene dye | fluorescent probe; fluorochrome; histological dye |
kalata b1 | [no description available] | medium | 1 | 0 | | |
vanadium | [no description available] | medium | 1 | 0 | elemental vanadium; vanadium group element atom | micronutrient |
hydrobromic acid | [no description available] | medium | 1 | 0 | gas molecular entity; hydrogen halide; mononuclear parent hydride | mouse metabolite |
heme | [no description available] | medium | 1 | 0 | | |
tryptophan | [no description available] | medium | 2 | 0 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan | antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite |
1-oleoyl-2-palmitoylphosphatidylcholine | [no description available] | medium | 1 | 0 | | |
gadolinium dtpa | [no description available] | medium | 3 | 0 | gadolinium coordination entity | MRI contrast agent |
1,2-dipalmitoyl-3-phosphatidylethanolamine | [no description available] | medium | 10 | 0 | | |
amyloid beta-peptides | [no description available] | medium | 1 | 0 | | |
fluorexon | [no description available] | medium | 1 | 0 | xanthene dye | fluorochrome |
atrazine | [no description available] | medium | 1 | 0 | chloro-1,3,5-triazine; diamino-1,3,5-triazine | environmental contaminant; herbicide; xenobiotic |
ammonium sulfate | [no description available] | medium | 1 | 0 | ammonium salt; inorganic sulfate salt | fertilizer |
17-n,n-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one | [no description available] | medium | 1 | 0 | | |
ammonium peroxydisulfate | [no description available] | medium | 1 | 0 | | |
n,n,n',n'-tetramethylethylenediamine | [no description available] | medium | 1 | 0 | ethylenediamine derivative | catalyst; chelator |
dihydrotestosterone | [no description available] | medium | 1 | 0 | 17beta-hydroxy steroid; 17beta-hydroxyandrostan-3-one; 3-oxo-5alpha-steroid | androgen; Daphnia magna metabolite; human metabolite; mouse metabolite |
stearylamine | [no description available] | medium | 2 | 0 | primary aliphatic amine | film-forming compound |
1,2-dipalmitoylphosphatidylglycerol | [no description available] | medium | 2 | 0 | phosphatidylglycerol | |
dipalmitoylphosphatidylserine | [no description available] | medium | 1 | 0 | phosphatidyl-L-serine | |
dapi | [no description available] | medium | 1 | 0 | indoles | fluorochrome |
methanol | [no description available] | medium | 2 | 0 | alkyl alcohol; one-carbon compound; primary alcohol; volatile organic compound | amphiprotic solvent; Escherichia coli metabolite; fuel; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite |
1-palmitoyl-2-oleoylphosphatidylcholine | [no description available] | medium | 2 | 0 | | |
citric acid, anhydrous | [no description available] | medium | 1 | 0 | tricarboxylic acid | antimicrobial agent; chelator; food acidity regulator; fundamental metabolite |
titanium citrate | [no description available] | medium | 1 | 0 | | |
chlordan | [no description available] | medium | 1 | 0 | cyclodiene organochlorine insecticide | GABA-gated chloride channel antagonist; persistent organic pollutant |
procaine | [no description available] | medium | 2 | 0 | benzoate ester; substituted aniline; tertiary amino compound | central nervous system depressant; drug allergen; local anaesthetic; peripheral nervous system drug |
unithiol | [no description available] | medium | 2 | 0 | | |
1-palmitoyl-2-linoleoylphosphatidylcholine | [no description available] | medium | 1 | 0 | | |
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc | [no description available] | medium | 2 | 0 | amino tetrasaccharide; glucosamine oligosaccharide | epitope |
acetylene | [no description available] | medium | 1 | 0 | alkyne; gas molecular entity; terminal acetylenic compound | |
nitrilotriacetic acid | [no description available] | medium | 1 | 0 | NTA; tricarboxylic acid | carcinogenic agent; nephrotoxic agent |
tetramethylrhodamine | [no description available] | medium | 1 | 0 | xanthene dye | |
sodium arsenite | [no description available] | medium | 1 | 0 | arsenic molecular entity; inorganic sodium salt | antibacterial agent; antifungal agent; antineoplastic agent; carcinogenic agent; herbicide; insecticide; rodenticide |
lanosterol | [no description available] | medium | 1 | 0 | 14alpha-methyl steroid; 3beta-sterol; tetracyclic triterpenoid | bacterial metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite |
maleic anhydride | [no description available] | medium | 1 | 0 | cyclic dicarboxylic anhydride; furans | allergen |
lithium | [no description available] | medium | 1 | 0 | alkali metal atom | |
lithium carbonate | [no description available] | medium | 1 | 0 | carbonate salt; lithium salt | antimanic drug |
arsenazo iii | [no description available] | medium | 1 | 0 | | |
nystatin a1 | [no description available] | medium | 1 | 0 | nystatins | |
trehalose | [no description available] | medium | 1 | 0 | trehalose | Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
arsenic | [no description available] | medium | 1 | 0 | metalloid atom; pnictogen | micronutrient |
monomethylarsonic acid | [no description available] | medium | 1 | 0 | arsonic acids; one-carbon compound; organoarsonic acid | |
arsenic acid | [no description available] | medium | 1 | 0 | arsenic oxoacid | Escherichia coli metabolite |
aminopenicillanic acid | [no description available] | medium | 1 | 0 | amino acid zwitterion; penicillanic acids | allergen |
penicillanic acid | [no description available] | medium | 1 | 0 | penicillanic acids | |
beta-lactams | [no description available] | medium | 1 | 0 | beta-lactam antibiotic allergen; beta-lactam | |
technetium | [no description available] | medium | 1 | 0 | manganese group element atom | |
galactose | [no description available] | medium | 1 | 0 | D-galactose; galactopyranose | Escherichia coli metabolite; mouse metabolite |
stavudine | [no description available] | medium | 1 | 0 | dihydrofuran; nucleoside analogue; organic molecular entity | antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor |
dimyristoylphosphatidic acid | [no description available] | medium | 1 | 0 | phosphatidic acid | |
deuterium | [no description available] | medium | 2 | 0 | dihydrogen | |
tetracaine | [no description available] | medium | 1 | 0 | benzoate ester; tertiary amino compound | local anaesthetic |
4-chloro-7-nitrobenzofurazan | [no description available] | medium | 2 | 0 | benzoxadiazole; C-nitro compound; organochlorine compound | EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.6.1.3 (adenosinetriphosphatase) inhibitor; fluorescent probe; fluorochrome |
quinidine | [no description available] | medium | 1 | 0 | cinchona alkaloid | alpha-adrenergic antagonist; anti-arrhythmia drug; antimalarial; drug allergen; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor; muscarinic antagonist; P450 inhibitor; potassium channel blocker; sodium channel blocker |
surfactin peptide | [no description available] | medium | 1 | 0 | | |
n,n-dimethyl-4-anisidine | [no description available] | medium | 1 | 0 | | |
procainamide | [no description available] | medium | 1 | 0 | benzamides | anti-arrhythmia drug; platelet aggregation inhibitor; sodium channel blocker |
phosphorylethanolamine | [no description available] | medium | 1 | 0 | phosphoethanolamine; primary amino compound | algal metabolite; human metabolite; mouse metabolite |
methotrexate | [no description available] | medium | 6 | 0 | dicarboxylic acid; monocarboxylic acid amide; pteridines | abortifacient; antimetabolite; antineoplastic agent; antirheumatic drug; dermatologic drug; DNA synthesis inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; immunosuppressive agent |
gentamicin | [no description available] | medium | 1 | 0 | | |
asocainol | [no description available] | medium | 1 | 0 | | |
1,2-dielaidoylphosphatidylethanolamine | [no description available] | medium | 7 | 0 | | |
penicillin g | [no description available] | medium | 1 | 0 | penicillin allergen; penicillin | antibacterial drug; drug allergen; epitope |
diphenylhexatriene | [no description available] | medium | 3 | 0 | alkatriene | fluorochrome |
agent orange | [no description available] | medium | 1 | 0 | | |
2,4-dichlorophenoxyacetic acid | [no description available] | medium | 1 | 0 | chlorophenoxyacetic acid; dichlorobenzene | agrochemical; defoliant; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; environmental contaminant; phenoxy herbicide; synthetic auxin |
2,4,5-trichlorophenoxyacetic acid | [no description available] | medium | 1 | 0 | chlorophenoxyacetic acid; trichlorobenzene | defoliant; phenoxy herbicide; synthetic auxin |
heptachlor | [no description available] | medium | 1 | 0 | cyclodiene organochlorine insecticide | agrochemical; antibacterial agent; antifungal agent; GABA-gated chloride channel antagonist; persistent organic pollutant |
warfarin | [no description available] | medium | 1 | 0 | benzenes; hydroxycoumarin; methyl ketone | |
beta carotene | [no description available] | medium | 1 | 0 | carotenoid beta-end derivative; cyclic carotene | antioxidant; biological pigment; cofactor; ferroptosis inhibitor; human metabolite; mouse metabolite; plant metabolite; provitamin A |
astaxanthine | [no description available] | medium | 1 | 0 | carotenol; carotenone | animal metabolite; anticoagulant; antioxidant; food colouring; plant metabolite |
dieldrin | [no description available] | medium | 1 | 0 | epoxide; organochlorine compound; organochlorine insecticide | carcinogenic agent; xenobiotic |
1,2-dilauroylphosphatidylethanolamine | [no description available] | medium | 4 | 0 | | |
lanthanum | [no description available] | medium | 1 | 0 | f-block element atom; lanthanoid atom; scandium group element atom | |
ytterbium dtpa | [no description available] | medium | 1 | 0 | | |
pyrazon | [no description available] | medium | 1 | 0 | benzenes; organochlorine compound; primary amino compound; pyridazinone | environmental contaminant; herbicide; xenobiotic |
thulium | [no description available] | medium | 1 | 0 | f-block element atom; lanthanoid atom | |
ytterbium | [no description available] | medium | 1 | 0 | f-block element atom; lanthanoid atom | |
urea | [no description available] | medium | 1 | 0 | isourea; monocarboxylic acid amide; one-carbon compound | Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
texas red | [no description available] | medium | 1 | 0 | organic heteroheptacyclic compound | fluorochrome |
xanthenes | [no description available] | medium | 1 | 0 | xanthene | |
tris(acetylacetonate) aluminum(iii) | [no description available] | medium | 1 | 0 | | |
1,2-distearoyllecithin | [no description available] | medium | 1 | 0 | | |
daunorubicin | [no description available] | medium | 1 | 0 | aminoglycoside antibiotic; anthracycline; p-quinones; tetracenequinones | antineoplastic agent; bacterial metabolite |
2-(dimethylamino)ethyl methacrylate | [no description available] | medium | 1 | 0 | | |
mercuric chloride | [no description available] | medium | 1 | 0 | mercury coordination entity | sensitiser |
1,2-dihexanoylglycerol | [no description available] | medium | 1 | 0 | 1,2-diglyceride | |
dibucaine | [no description available] | medium | 1 | 0 | aromatic ether; monocarboxylic acid amide; tertiary amino compound | topical anaesthetic |
triphenyltin chloride | [no description available] | medium | 1 | 0 | chlorine molecular entity; organotin compound | antifungal agrochemical; immunosuppressive agent |
benomyl | [no description available] | medium | 1 | 0 | aromatic amide; benzimidazole fungicide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester | acaricide; anthelminthic drug; antifungal agrochemical; microtubule-destabilising agent; tubulin modulator |
1,2-linoleoylphosphatidylcholine | [no description available] | medium | 1 | 0 | | |
genistein | [no description available] | medium | 1 | 0 | 7-hydroxyisoflavones | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor |
biochanin a | [no description available] | medium | 1 | 0 | 4'-methoxyisoflavones; 7-hydroxyisoflavones | antineoplastic agent; EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor; phytoestrogen; plant metabolite; tyrosine kinase inhibitor |
lysophosphatidylethanolamine | [no description available] | medium | 1 | 0 | | |
myristic acid | [no description available] | medium | 2 | 0 | long-chain fatty acid; straight-chain saturated fatty acid | algal metabolite; Daphnia magna metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite |
2-hydroxy-1-naphthaldehyde | [no description available] | medium | 1 | 0 | naphthaldehydes; naphthols | |
biotin | [no description available] | medium | 3 | 0 | biotins; vitamin B7 | coenzyme; cofactor; Escherichia coli metabolite; fundamental metabolite; human metabolite; mouse metabolite; nutraceutical; prosthetic group; Saccharomyces cerevisiae metabolite |
dodecyloctaethyleneglycol monoether | [no description available] | medium | 1 | 0 | hydroxypolyether | |
cholesteryl oleate | [no description available] | medium | 1 | 0 | CE(18:1); cholesteryl octadec-9-enoate | mouse metabolite |
chlortetracycline | [no description available] | medium | 1 | 0 | | |
abscisic acid | [no description available] | medium | 1 | 0 | 2-trans-abscisic acid | |
1-propanol | [no description available] | medium | 1 | 0 | propan-1-ols; short-chain primary fatty alcohol | metabolite; protic solvent |
tocopherols | [no description available] | medium | 1 | 0 | | |
2,3,4,6-tetrachlorophenol | [no description available] | medium | 1 | 0 | tetrachlorophenol | xenobiotic metabolite |
pentachlorophenol | [no description available] | medium | 1 | 0 | aromatic fungicide; chlorophenol; organochlorine pesticide; pentachlorobenzenes | human xenobiotic metabolite |
parinaric acid | [no description available] | medium | 1 | 0 | octadecatetraenoic acid | |
dimethyl suberimidate | [no description available] | medium | 1 | 0 | | |
ammonium chloride | [no description available] | medium | 2 | 0 | ammonium salt; inorganic chloride | ferroptosis inhibitor |
chlorpromazine | [no description available] | medium | 1 | 0 | organochlorine compound; phenothiazines; tertiary amine | anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug |
ovalbumin | [no description available] | medium | 1 | 0 | | |
iodoacetic acid | [no description available] | medium | 1 | 0 | haloacetic acid; organoiodine compound | alkylating agent |
glycerophosphoethanolamine | [no description available] | medium | 2 | 0 | phosphoethanolamine; sn-glycerol 3-phosphates | |
thiamine pyrophosphate | [no description available] | medium | 1 | 0 | organic chloride salt; vitamin B1 | |
deoxyuridine | [no description available] | medium | 1 | 0 | pyrimidine 2'-deoxyribonucleoside | Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |